Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Other Non-Current Assets (2016 - 2025)

PAVmed has reported Other Non-Current Assets over the past 6 years, most recently at $56000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 73.08% year-over-year to $56000.0; the TTM value through Dec 2025 reached $56000.0, down 73.08%, while the annual FY2025 figure was $56000.0, 73.08% down from the prior year.
  • Other Non-Current Assets for Q4 2025 was $56000.0 at PAVmed, down from $262000.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $1.7 million in Q2 2022 and troughed at $56000.0 in Q4 2025.
  • A 5-year average of $818950.0 and a median of $948000.0 in 2021 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: surged 66.67% in 2022 and later crashed 81.87% in 2024.
  • Year by year, Other Non-Current Assets stood at $725000.0 in 2021, then soared by 54.62% to $1.1 million in 2022, then increased by 2.32% to $1.1 million in 2023, then crashed by 81.87% to $208000.0 in 2024, then plummeted by 73.08% to $56000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for PAVM at $56000.0 in Q4 2025, $262000.0 in Q3 2025, and $373000.0 in Q2 2025.